|
|
Post by babaoriley on Sept 7, 2017 16:21:14 GMT -5
My thought, a bit simpler: he pissed off Mike. Maybe but since he had a new job already lined up on september 1st, to me that indicates he left of his own free will. If Mike had fired him, Mannkind would have planned to get a replacement before he was let go. My hope is that Locust Walk found someone to take on the costs of R+D for Mannkind, maybe it's a third party with a similar agreement as receptor or perhaps they are planning to bring in their own CMO. I hope Ray did not leave on his own volition, that would not dovetail well with the rosy future many predict for the company. IMO, he was asked to leave, and likely given time to find a position. |
|
|
|
Post by nylefty on Sept 7, 2017 16:34:51 GMT -5
Today's pr stated he started 9/1. The company's website is out of date at this point because it has a new name.
A side note on reverse splits since we all love them so much. This company announced a 300-1 RS. Stock was trading at $.06, then opened at $18 on 8/21. Looks like its going to close at $8 today. Fun with numbers: If MannKind also did a 300-1 reverse split we'd have a $594 stock to brag about! |
|
|
|
Post by mnholdem on Sept 7, 2017 16:38:34 GMT -5
Maybe but since he had a new job already lined up on september 1st, to me that indicates he left of his own free will. If Mike had fired him, Mannkind would have planned to get a replacement before he was let go. My hope is that Locust Walk found someone to take on the costs of R+D for Mannkind, maybe it's a third party with a similar agreement as receptor or perhaps they are planning to bring in their own CMO. I hope Ray did not leave on his own volition, that would not dovetail well with the rosy future many predict for the company. IMO, he was asked to leave, and likely given time to find a position. We'll find out soon enough. I'm pretty sure that the departure of an Officer or Director is a material event that must be reported [5.02] on an 8-K filing. |
|
|
|
Post by dreamboatcruise on Sept 7, 2017 16:47:18 GMT -5
Maybe but since he had a new job already lined up on september 1st, to me that indicates he left of his own free will. If Mike had fired him, Mannkind would have planned to get a replacement before he was let go. My hope is that Locust Walk found someone to take on the costs of R+D for Mannkind, maybe it's a third party with a similar agreement as receptor or perhaps they are planning to bring in their own CMO. I hope Ray did not leave on his own volition, that would not dovetail well with the rosy future many predict for the company. IMO, he was asked to leave, and likely given time to find a position. I wouldn't necessarily think it horrible even if he decided to leave. He has options he gets to hold onto. Seems he's moving to a company that matches his oncology background better. I'm sure he didn't like having to sell/kill off that division. Plus I wouldn't be surprised if Sports isn't right and that they may sell off all of TS to fund Afrezza, thus shutting down the pipeline (though credit to me as well if it happens as I've posed that as a possibility ever sense the firm was hired to shop pipeline assets). |
|
|
|
Post by barnstormer on Sept 7, 2017 16:54:13 GMT -5
Pfizer failed inhaled insulin with Exhubra. If I were Urbanski I'd keep Pfizer off my resume too. Probably juiced his application. I'd say he wasn't Mike's man. Bring in some proven talent. Ray was an "Also Ran" .
|
|
|
|
Post by porkini on Sept 7, 2017 17:37:57 GMT -5
Urbanksy was from the prior regime so it would not be a surprise if this is coming from Mike and he has another sharp replacement. The PR may be waiting for the replacement to officially leave a current position to be able to make an announcement. Obviously the price action really didn't flinch so looks like it's a non-issue and actually may be construed positively with any announcement. Unless you were on the other side of the coin, then the price flinched a lot! GT Biopharma Inc Quote & Summary Data OXISD $8.4* -2.58-23.50 % *Delayed - data as of Sep. 7, 2017 |
|
|
|
Post by mango on Sept 7, 2017 17:43:15 GMT -5
I'm calling that they no way in hell will sell all of Technosphere IP.
|
|
|
|
Post by bioexec25 on Sept 7, 2017 17:43:59 GMT -5
Sports either spot on or in the ballpark imo. Could be an outright sell of TS or perhaps an exclusive tech license deal of some kind. Makes sense that a twenty year old technology needs to go somewhere it can be invested in and synergistically applied across multiple therapeutics. Maybe Mnkd reserves the rights to use it on selective agreed pipeline areas. Anyway think of a 3-4 year runway on an emerging best (only) in class Afrezza. Blockbuster does come to mind. Fast forward and shorts and the street will hammer us as a one trick pony on the cusp of genericland. Strike that thought. A lot can change and let's enjoy the next few years.
|
|
|
|
Post by uvula on Sept 7, 2017 17:47:49 GMT -5
I'm calling that they no way in hell will sell all of Technosphere IP. If it isn't sold it would probably be because no one wanted to buy it. Mnkd has a responsibly to at least explore all possibilities. I'm sure selling technosphere IP has been discussed. |
|
|
|
Post by sportsrancho on Sept 7, 2017 17:53:12 GMT -5
MRK comes to mind:-)
|
|
|
|
Post by rockstarrick on Sept 7, 2017 18:13:44 GMT -5
((((((((((BOOM !!!)))))))))) |
|
|
|
Post by robbmo on Sept 7, 2017 18:17:46 GMT -5
Maybe but since he had a new job already lined up on september 1st, to me that indicates he left of his own free will. If Mike had fired him, Mannkind would have planned to get a replacement before he was let go. My hope is that Locust Walk found someone to take on the costs of R+D for Mannkind, maybe it's a third party with a similar agreement as receptor or perhaps they are planning to bring in their own CMO. I hope Ray did not leave on his own volition, that would not dovetail well with the rosy future many predict for the company. IMO, he was asked to leave, and likely given time to find a position. I agree with you. I do not believe he made the cut. He "left" Mylan and was a "consultant" for a year before we picked him up. It has always been questionable in my mind. |
|
|
|
Post by careful2invest on Sept 7, 2017 18:49:44 GMT -5
I'm calling that they no way in hell will sell all of Technosphere IP. I second that! Technosphere has way too much potential to let go of. Not to mention, future potential is hard to put a price on. GLTA! |
|
|
|
Post by agedhippie on Sept 7, 2017 18:59:47 GMT -5
I'm calling that they no way in hell will sell all of Technosphere IP. I second that! Technosphere has way too much potential to let go of. Not to mention, future potential is hard to put a price on. GLTA! I can see that happening. It's either Afrezza or TI and only Afrezza is generating an immediate cashflow. The route would be to sell TI and keep a license to use it in future Mannkind products. |
|
|
|
Post by mango on Sept 7, 2017 19:15:46 GMT -5
I second that! Technosphere has way too much potential to let go of. Not to mention, future potential is hard to put a price on. GLTA! I can see that happening. It's either Afrezza or TI and only Afrezza is generating an immediate cashflow. The route would be to sell TI and keep a license to use it in future Mannkind products. I see them making more licensing deals for sure. Out right selling it, I don't think so. IMO |
|
